$ABEO News Article - Abeona Therapeutics Announces Successful Type B Meeting with FDA for Pivotal Phase 3 VIITAL(TM) Study of EB-101 in Recessive Dystrophic Epidermolysis Bullosa (RDEB) https://marketwirenews.com/news-releases/abeo...46995.html
(0)
(0)
Abeona Therapeutics Inc. (ABEO) Stock Research Links